Education ▼

Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

SPECIALTY TOPICS

CURRENTLY VIEWING
Immunotherapy in Melanoma

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Immunotherapy in Melanoma

Adjuvant Ipilimumab Improves OS in High-Risk Melanoma

Adjuvant treatment with ipilimumab, when given at a 3-mg/kg dose, was found to improve overall survival compared with high-dose interferon alfa in patients with high-risk melanoma.
Read More >>

CTC Detection Linked to Relapse in Stage III Melanoma

ASCO Names Refinement of Surgical Treatment of Cancer as Advance of the Year

Investigators Tackle Resistance, Poor Response in Metastatic Melanoma

Surgical Resection Now Individualized Approach in Modern Melanoma Paradigm

View More Stories >>

View Conference Coverage

2020 HCC-TAG Conference

2020 International Congress on Hematologic Malignancies

2020 Transplantation & Cellular Therapy Meetings

2020 Winter Lung Cancer Conference

2020 Genitourinary Cancers Symposium

Dr. Liebman on the Use of Digital Surveillance in Melanoma

Dr. Shapiro on the Surgical Management of Advanced-Stage Melanoma

Dr. Weber on Emerging Immunotherapy Combinations in Melanoma

Nuances of Immunotherapy-Related AEs in Melanoma

Experts Share What They're Going to Work on Improving in Practice This Year

Dr. Liebman on Toxicities of BRAF Inhibitors in Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Checkpoint Inhibitors in Second and Third-line

Unmet Needs and Future Treatments of Metastatic Melanoma

The Use of Dual Targeted Therapy in Metastatic Melanoma

$Management of Relapsed/Refractory Metastatic Melanoma$

Immunotherapy vs TKIs in BRAF+ Metastatic Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

Emerging Treatment Strategies for Advanced BRAF+ Melanoma

Sequencing Therapy in Metastatic BRAF+ Melanoma

Selecting Therapy & Managing Patients With BRAF+ Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Metastatic Melanoma: The New Millennium

Keith Flaherty, MD, moderates this discussion with Rene Gonzalez, MD, Jason Luke, MD, FACP, and Jeffrey Weber, MD, PhD. The panel of experts in melanoma research and treatment talk about the most recent advances in the field, and provide perspective on how to apply the newest data to individualize treatment strategies.

View Now

Dr. Hodi on Long-Term Survival Data for Nivolumab in Melanoma

F. Stephen Hodi, MD, director of the Melanoma Center at Dana-Farber Cancer Institute, and investigator at the Ludwig Center at Harvard, discusses the results of a 5-year follow-up analysis of survival outcomes of patients with advanced melanoma who were treated with single-agent nivolumab (Opdivo).

View Now

Featured Video

Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer

Christina Tan, MD, MPH, state epidemiologist, assistant commissioner, New Jersey Department of Health, discusses the potential impact of the novel coronavirus on patients with cancer. View now

OncLive News Network On Location: 2020 Transplantation & Cellular Therapy Meetings